Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine

Affiliations

¹ Department of Medical and Surgical Sciences, Institute of Neurology, Magna Græcia University, V.le Europa, 88100, Catanzaro, Italy.
² Department of Medical and Surgical Sciences, Institute of Neurology, Magna Græcia University, V.le Europa, 88100, Catanzaro, Italy. a.gambardella@unicz.it.

Michele Trimboli et al. Neurol Sci. 2021 Nov.

. 2021 Nov;42(11):4401-4402.

doi: 10.1007/s10072-021-05523-5. Epub 2021 Aug 4.

¹ Department of Medical and Surgical Sciences, Institute of Neurology, Magna Græcia University, V.le Europa, 88100, Catanzaro, Italy.
² Department of Medical and Surgical Sciences, Institute of Neurology, Magna Græcia University, V.le Europa, 88100, Catanzaro, Italy. a.gambardella@unicz.it.

No abstract available

Conflict of interest statement

The authors declare no competing interests.

1. Willison HJ, Jacobs BC, van Doorn PA. Guillain-Barre syndrome. Lancet. 2016;388:717–727. doi: 10.1016/S0140-6736(16)00339-1. - DOI - PubMed
1. Jacobs BC, Rothbarth PH, van der Meché FG, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology. 1998;51:1110–1115. doi: 10.1212/WNL.51.4.1110. - DOI - PubMed
1. Cao-Lormeau VM, Blake A, Monset S, et al. Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387:1531–1539. doi: 10.1016/S0140-6736(16)00562-6. - DOI - PMC - PubMed
1. Van den Berg B, Van Der Eijk AA, Pas SD, et al. Guillain-Barrè syndrome associated with preceding hepatitis E virus infection. Neurology. 2014;82:491–497. doi: 10.1212/WNL.0000000000000111. - DOI - PubMed
1. Yuki N, Hartung HP. Guillain-Barrè syndrome. N Engl J Med. 2012;366:2294–2304. doi: 10.1056/NEJMra1114525. - DOI - PubMed